Jaguar Health JAGX
NASDAQ JAGX
$3.66 -0.29 (-7.34%)
At close: Oct 2, 2026 · 4:00 PM EDT

Jaguar Health (JAGX) Return on Sales [ROS] (2015 - 2026)

Updated

Jaguar Health's Return on Sales [ROS] was -620.16% in Q2 2026, down 351.38 percentage points from -268.78% a year earlier and down 670.39 percentage points from the prior quarter.

Analysis

Jaguar Health (JAGX) Return on Sales [ROS] (2015 - 2026) Analysis & Trends

On a trailing twelve-month basis, Jaguar Health's Return on Sales [ROS] was -93.10% through Jun 30, 2026, up 185.03 percentage points year-over-year; for FY2025, it came in at -398.82%, down 135.06 percentage points from FY2024.

  • Return on Sales [ROS] shows a five-year change of -114.89 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Sales [ROS] was -263.76% in FY2024 (+87.55 pp), -351.31% in FY2023 (-63.46 pp), -287.85% in FY2022 (+651.21 pp) and -939.05% in FY2021 (-655.12 pp).
  • Quarterly Return on Sales [ROS] has moved between -1512.54% (Q3 2021) and 50.23% (Q1 2026) over five years.
  • Compared with a year earlier, Return on Sales [ROS] was higher in three of the last eight quarters, with an average year-over-year change of -25.81 percentage points.
  • The best year-over-year quarter for Return on Sales [ROS] over five years was Q2 2022 (a gain of 2785.98 percentage points); the worst was Q3 2021 (a drop of 1318.71 percentage points).
  • Per Business Quant data, JAGX's Return on Sales [ROS] in the three quarters before Q2 2026 was 50.23% (Q1 2026), -656.63% (Q4 2025) and -234.77% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 28.21%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 37.86%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -3.52%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 32.97%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 20.57%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 34.95%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -133.21%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 28.37%
10 Jaguar Health 585,790.33 -16.67 Mn 194,000.00 -620.16%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -620.16%
Mar 31, 2026 50.23%
Dec 31, 2025 -656.63%
Sep 30, 2025 -234.77%
Jun 30, 2025 -268.78%
Mar 31, 2025 -425.52%
Dec 31, 2024 -232.46%
Sep 30, 2024 -233.66%
Jun 30, 2024 -264.50%
Mar 31, 2024 -349.43%
Dec 31, 2023 -328.57%
Sep 30, 2023 -312.37%
Jun 30, 2023 -302.77%
Mar 31, 2023 -499.24%
Dec 31, 2022 -192.82%
Sep 30, 2022 -314.16%
Jun 30, 2022 -221.81%
Mar 31, 2022 -447.77%
Dec 31, 2021 -520.29%
Sep 30, 2021 -1,512.54%
API Access

Jaguar Health Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=JAGX&period=max&api_key=YOUR_API_KEY